Peter D Haytaian
CIK 1608538 · EVP & Pres Carelon & CarelonRx · last filed 2026-03-04
Peter D Haytaian is an EVP & Pres Carelon & CarelonRx who has filed 47 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for ELV, was dated Mar 4, 2026. Across all open-market trades the lifetime net is −$67.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.81M
4
47
-$67.44M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELV | EVP & Pres Carelon & CarelonRx | 24,803 | $385.73 | $9.57M | -$10.55M | 7 | 2026-03-04 |
| Elevance Health, Inc. (ANTM) Delisted | EVP & Pres., DBG & IngenioRx | 13,441 | $482.58 | $6.49M | -$56.89M | 28 | 2022-03-14 |
| ANTX | EVP & President, GBD | 52,653 | $4.70 | $247.5K | $0 | 10 | 2018-03-05 |
| Elevance Health, Inc. (WLP) Delisted | EVP & Pres., Govt. Bus. Div. | 45,037 | — | — | $0 | 1 | 2014-12-03 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-04 | ELV | Mixed | +1,218 | -$479.9K | EDGAR |
| 2025-03-05 | ELV | Mixed | +4,967 | -$902.1K | EDGAR |
| 2024-11-05 | ELV | Mixed | +2,150 | -$682.7K | EDGAR |
| 2024-03-05 | ELV | Mixed | +1,148 | -$10.20M | EDGAR |
| 2024-03-04 | ELV | Notice (144) | −21,095 | -$10.55M | EDGAR |
| 2023-11-03 | ELV | Tax (F) | −154 | -$68.8K | EDGAR |
| 2023-03-03 | ELV | Mixed | +5,932 | -$2.85M | EDGAR |
| 2022-11-03 | ELV | Tax (F) | −200 | -$108.9K | EDGAR |
| 2022-03-14 | Elevance Health, Inc. (ANTM) Delisted | Mixed | −15,855 | -$7.91M | EDGAR |
| 2022-03-03 | Elevance Health, Inc. (ANTM) Delisted | Mixed | +5,305 | -$2.34M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.